Showing results (601-610 of 2,528) with videos related to

Sort By:
Pageof 253
Diagnostic Pathology|May 22, 2024
Thyroid papillary carcinoma combined with primary follicular lymphoma: a case reportTing Xu, Li Wu, Hua Ye, et al.
Diagnostic Pathology|December 23, 2025
Tumor-infiltrating neutrophil is an independent prognostic factor in pancreatic ductal adenocarcinomaSeung-Myoung Son, Hye Sook Han, Ho-Chang Lee, et al.
Diagnostic Pathology|December 13, 2025
Low CDX2 expression and its clinicopathological associations in colorectal adenocarcinoma: prognostic insights from a retrospective cross-sectional study in VietnamHuy Minh Le, Tram Ho Ngoc Le, Hanh Thi Tuyet Ngo, et al.
Diagnostic Pathology|December 17, 2025
Assessment of histopathology and cytology request form documentation quality using six Sigma and Pareto analysis in Benghazi, LibyaHussien Hamid, Hamza Naas, Mohamed A Alshaqabi, et al.
Diagnostic Pathology|December 22, 2025
Application value of TPAS staining technique for cervical exfoliated cells in cervical cancer screeningGuo Chen, Wenli Zhang, Yuchen HuYan, et al.
Diagnostic Pathology|November 28, 2025
Aberrant TTF-1 expression in metastatic colorectal adenocarcinoma mimicking primary lung cancer: a case report and review of diagnostic pitfallsNhu Tung Tran, Nguyen Van Thai, Nguyen Thi Khuyen, et al.
Diagnostic Pathology|April 27, 2024
Low-grade undifferentiated sarcoma with MEIS1::NCOA2-rearrangement primary to the lung: a case reportZachary Coty-Fattal, Bianca Carter, Michael J Volek, et al.
Diagnostic Pathology|May 10, 2024
A rare case of TFEB/6p21/VEGFA-amplified renal cell carcinoma diagnosed by whole-exome sequencing: clinicopathological and genetic feature report and literature reviewRuiqi Zhang, Meili Ding, Xingyao Zhu, et al.
Diagnostic Pathology|April 16, 2024
MNDA expression and its value in differential diagnosis of B-cell non-Hodgkin lymphomas: a comprehensive analysis of a large series of 1293 casesLi-Fen Zhang, Yan Zhang, Rou-Hong Shui, et al.
Diagnostic Pathology|January 4, 2024
Estrogen receptor-negative/progesterone receptor-positive breast cancer has distinct characteristics and pathologic complete response rate after neoadjuvant chemotherapyHe Dou, Fucheng Li, Youyu Wang, et al.
Pageof 253